Abstract
We have studied the pathways of regulation of cytokine and cell cycle control proteins during infection of human B lymphocytes by Epstein-Barr virus (EBV). Among 30 cytokine RNAs analyzed by the RNase protection assay, tumor necrosis factor alpha (TNF-alpha), granulocyte colony-stimulating factor, lymphotoxin (LT), and LTbeta were found to be regulated within 20 h of EBV infection of primary B cells. Similar results were obtained using the estrogen-regulated EBNA-2 cell line EREB2.5, in which RNAs for LT and TNF-alpha were induced within 6 h of activation of EBNA-2. Expression of Notch also caused an induction of TNF-alpha RNA. The induction of TNF-alpha RNA by EBNA-2 was indirect, and constitutive expression of either LMP-1 or c-myc proteins did not substitute for EBNA-2 in induction of TNF-alpha RNA. Cyclin D2 is also an indirect target of EBNA-2-mediated transactivation. EBNA-2 was found to activate the cyclin D2 promoter in a transient-transfection assay. A mutant of EBNA-2 that does not bind RBP-Jkappa retained some activity in this assay, and activation did not depend on the presence of B-cell-specific factors. Deletion analysis of the cyclin D2 promoter revealed that removal of sequences containing E-box c-myc consensus DNA binding sequences did not reduce EBNA-2-mediated activation of the cyclin D2 promoter in the transient-transfection assay. The results indicate that cytokines are an early target of EBNA-2 and that EBNA-2 can regulate cyclin D2 transcription in EBV-infected cells by mechanisms additional to the c-myc pathway.
MeSH terms
-
Adaptor Proteins, Signal Transducing
-
Anisomycin / pharmacology
-
B-Lymphocytes / metabolism*
-
B-Lymphocytes / virology*
-
Carrier Proteins / genetics
-
Carrier Proteins / metabolism
-
Cell Cycle Proteins / genetics*
-
Cells, Cultured
-
Cyclin D2
-
Cyclin-Dependent Kinase Inhibitor p27
-
Cyclins / genetics
-
Cyclins / metabolism
-
Cycloheximide / pharmacology
-
Cytokines / genetics*
-
Cytoskeletal Proteins
-
Epstein-Barr Virus Nuclear Antigens / genetics
-
Epstein-Barr Virus Nuclear Antigens / metabolism*
-
Estrogens / pharmacology
-
Fluorescent Antibody Technique
-
Gene Expression Regulation* / drug effects
-
Granulocyte Colony-Stimulating Factor / genetics
-
Herpesvirus 4, Human / physiology*
-
Humans
-
Intracellular Signaling Peptides and Proteins
-
LIM Domain Proteins
-
Lymphotoxin-alpha / genetics
-
Membrane Proteins / genetics
-
Membrane Proteins / metabolism
-
Microtubule-Associated Proteins / metabolism
-
Mutation / genetics
-
Nuclease Protection Assays
-
Promoter Regions, Genetic / genetics
-
Proto-Oncogene Proteins c-myc / genetics
-
Proto-Oncogene Proteins c-myc / metabolism
-
RNA, Messenger / genetics
-
RNA, Messenger / metabolism
-
Receptors, Notch
-
Transcription, Genetic / drug effects
-
Transcription, Genetic / genetics
-
Tumor Cells, Cultured
-
Tumor Necrosis Factor-alpha / genetics
-
Tumor Suppressor Proteins*
-
Viral Proteins
Substances
-
Adaptor Proteins, Signal Transducing
-
CCND2 protein, human
-
Carrier Proteins
-
Cell Cycle Proteins
-
Cyclin D2
-
Cyclins
-
Cytokines
-
Cytoskeletal Proteins
-
EBNA-2 protein, Human herpesvirus 4
-
Epstein-Barr Virus Nuclear Antigens
-
Estrogens
-
Intracellular Signaling Peptides and Proteins
-
LIM Domain Proteins
-
Lymphotoxin-alpha
-
Membrane Proteins
-
Microtubule-Associated Proteins
-
PDLIM7 protein, human
-
Proto-Oncogene Proteins c-myc
-
RNA, Messenger
-
Receptors, Notch
-
Tumor Necrosis Factor-alpha
-
Tumor Suppressor Proteins
-
Viral Proteins
-
Granulocyte Colony-Stimulating Factor
-
Cyclin-Dependent Kinase Inhibitor p27
-
Anisomycin
-
Cycloheximide